“…Screening organic solvent-tolerant bacteria or extremophiles has been preferred to isolate and improve naturally solvent-stable enzymes (Gupta & Khare, 2009;Doukyu & Ogino, 2010). Other protein engineering examples with industrially and/or pharmacologically important enzymes include studies on cholesterol oxidase (Pollegioni et al, 2009), cyclodextrin glucanotransferases (Leemhuis et al, 2010), human butyrylcholinesterase (Masson et al, 2009), microbial glucoamylases (Kumar & Satyanarayana, 2009), lipases of different origins (Akoh et al, 2004;Verma et al, 2008;Kurtovic et al, 2009), phospholipases (Song et al, 2005;De Maria et al, 2007;Simockova & Griac, 2009) and phytases (Rao et al, 2009). Studies on extremozymes, enzymes isolated from extremophilic species, revealed their different structural and functional characteristics which could be exploited for biotechnological applications and improved further by protein engineering (Bjarnason et al, 1993;Hough & Danson, 1999;Georlette et al, 2004).…”